Ogorek Anthony Joseph’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3K Hold
20
﹤0.01% 548
2026
Q1
$3K Hold
20
﹤0.01% 534
2025
Q4
$3K Hold
20
﹤0.01% 534
2025
Q3
$2K Hold
20
﹤0.01% 578
2025
Q2
$2K Hold
20
﹤0.01% 557
2025
Q1
$2K Hold
20
﹤0.01% 555
2024
Q4
$2K Buy
+20
New +$2.81K ﹤0.01% 277
2020
Q3
Sell
-105
Closed -$14K 192
2020
Q2
$14K Sell
105
-75
-42% -$9.56K 0.01% 101
2020
Q1
$19K Hold
180
0.01% 74
2019
Q4
$21K Hold
180
0.01% 81
2019
Q3
$17K Hold
180
0.01% 78
2019
Q2
$19K Hold
180
0.01% 71
2019
Q1
$20K Hold
180
0.01% 62
2018
Q4
$17K Hold
180
0.01% 66
2018
Q3
$21K Buy
+180
New +$21.2K 0.02% 59
2017
Q1
Sell
-378
Closed -$36K 70
2016
Q4
$36K Hold
378
0.03% 36
2016
Q3
$36K Hold
378
0.03% 36
2016
Q2
$32K Hold
378
0.03% 39
2016
Q1
$33K Hold
378
0.03% 39
2015
Q4
$43K Hold
378
0.04% 37
2015
Q3
$38K Hold
378
0.03% 33
2015
Q2
$46K Hold
378
0.04% 30
2015
Q1
$43K Buy
+378
New +$41.7K 0.03% 32

Other funds holding IBB

Ogorek Anthony Joseph's IBB Position: Q2 2026 in Review

Ogorek Anthony Joseph held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 20 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #548.

Ogorek Anthony Joseph first reported a position in IBB in Q1 2015 and has held it in 23 quarters since. The position peaked at $46K in Q2 2015. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Ogorek Anthony Joseph held 20 shares of iShares Biotechnology ETF worth $3K as of Q2 2026.
  • Ogorek Anthony Joseph left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Ogorek Anthony Joseph's portfolio in Q2 2026, its #548 holding.
  • Ogorek Anthony Joseph first reported a position in iShares Biotechnology ETF in Q1 2015 and has held it in 23 quarters since.
  • Ogorek Anthony Joseph's iShares Biotechnology ETF position peaked at $46K in Q2 2015.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Ogorek Anthony Joseph's 13F filing for Q2 2026, filed 7 Aug 2026.